Múltiples Factores de Riesgo: Reporte de Caso
DOI:
https://doi.org/10.21270/archi.v11i5.6008Palabras clave:
VIH, Síndrome de Inmunodeficiencia Adquirida, Papillomaviridae, Factores de Riesgo, Neoplasias de la Boca, Patología BucalResumen
El Virus de la Inmunodeficiencia Humana, cuando se asocia a una mala terapia antirretroviral o abandono del esquema terapéutico, es responsable del desarrollo del Síndrome de Inmunodeficiencia Adquirida, cuadro clínico de inmunosupresión que predispone al paciente a la aparición de infecciones oportunistas. La infección por el Virus del Papiloma Humano es una de las infecciones oportunistas más comunes y varios factores de riesgo pueden estar asociados con su prevalencia, incluidos el tabaquismo y el alcoholismo, que también contribuyen a la persistencia de la infección y posible cancerización de las lesiones causadas por el virus. El presente estudio tiene como objetivo reportar el caso clínico de un paciente masculino, ex fumador, ex alcohólico, ex consumidor de drogas con diagnóstico tardío del Virus de la Inmunodeficiencia Humana y con Síndrome de Down Inmunodeficiencia Adquirida, quien presentó leucoplasia en borde bilateral. de la lengua Fue necesaria la extirpación total de las lesiones y el análisis histopatológico mostró características de infección por el Virus del Papiloma Humano, además de displasia atípica con alta replicación viral y posibilidad de malignidad.
Descargas
Citas
Tavares. W., Marinho. LAC, Rotinas de diagnóstico e tratamento das doenças infecciosas e parasitárias 4.ed. 2015, Atheneu.
Macedo A, Barbosa A. Atendimento Odontológico De Portadores Hiv/Aids. Trabalho De Conclusão De Curso, Departamento De Odontologia Da Universidade De Taubaté. Taubaté, 2021;32.
Sa AAM, Santos CVM. A Vivência Da Sexualidade De Pessoas Que Vivem Com Hiv/Aids, Psicol cienc prof. 38 (4):773-86.
Kumar V, Abbas A. Fausto N. Robins, S. Cotran, R. S. Robbins E Cotran Base Patológica Da Doença. Saunders. 7.ed. 2004; 249.
Adurogbangba MI, Aderinokun GA, Odaibo GN, Olaleye OD, Lawoyin TO. Oro-facial lesions and CD4 counts associated with HIV/AIDS in an adult population in Oyo State, Nigeria. Oral Dis. 2004;10(6):319-26.
French Intensive Care Society, International congress - Réanimation 2016. Ann Intensive Care. 2016;6(Suppl 1):50.
Mitiku H, Weldegebreal F, Teklemariam Z. Magnitude of opportunistic infections and associated factors in HIV-infected adults on antiretroviral therapy in eastern Ethiopia. HIV AIDS (Auckl). 2015;7:137-44.
Gondivkar S, Sarode SC, Gadbail AR, Yuwanati M, Sarode GS, Gondivkar RS, Sengupta N, Patil S, Awan KH. Oro-facial opportunistic infections and related pathologies in HIV patients: A comprehensive review. Dis Mon. 2021;67(9):101170.
Looker KJ, Rönn MM, Brock PM, Brisson M, Drolet M, Mayaud P, Boily MC. Evidence of synergistic relationships between HIV and Human Papillomavirus (HPV): systematic reviews and meta-analyses of longitudinal studies of HPV acquisition and clearance by HIV status, and of HIV acquisition by HPV status. J Int AIDS Soc. 2018;21(6):e25110.
Feller L, Wood NH, Khammissa RA, Lemmer J. Human papillomavirus-mediated carcinogenesis and HPV-associated oral and oropharyngeal squamous cell carcinoma. Part 2: Human papillomavirus associated oral and oropharyngeal squamous cell carcinoma. Head Face Med. 2010;6:15.
Rivoire WA, Corleta HVE, Brum IS, Capp E. Biologia Molecular Do Câncer Cervical. Rev. Bras Saúde Matern Infant. 2006;6(4):447-51.
Schiffman M, Clifford G, Buonaguro FM. Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline. Infect Agent Cancer. 2009;4:8.
Pyeon D, Lambert PF, Ahlquest P. Production Of Infectious Human Differentiation. Proc Natl Acad Sci. 2005;102(26):9311-19.
Betiol J, Villa LL, Sichero L. Impact Of Hpv Infection On The Development Of Head And Neck Cancer. Braz J Med Biol Res. 2013;46(3):217-26.
Mooij SH, Boot HJ, Speksnijder AGCL, Stolte IG, Meijer CJLM, Snijders PJF, et al. Oral human papillomavirus infection in HIV-negative and HIV-infected MSM. AIDS (London, England) [Internet]. 2013;27(13):2117-28.
Dreyer G. Clinical implications of the interaction between HPV and HIV infections. Best Pract Res Clin Obstet Gynaecol. 2018;47:95-106.
Williamson AL. The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa. J Clin Med. 2015;4(4):579-92.
Williamson AL. The Interaction between Human Immunodeficiency Virus and Human Papillomaviruses in Heterosexuals in Africa. J Clin Med. 2015;4(4):579-92.
Beachler DC, Weber KM, Margolick JB, Strickler HD, Cranston RD, Burk RD, et al. Risk factors for oral HPV infection among a high prevalence population of HIV-positive and at-risk HIV-negative adults. Cancer Epidemiol Biomarkers Prev. 2012;21(1):122-33.
Hafkamp HC, Manni JJ, Haesevoets A, Voogd AC, Schepers M, Bot FJ, Hopman AH, Ramaekers FC, Speel EJ. Marked differences in survival rate between smokers and nonsmokers with HPV 16-associated tonsillar carcinomas. Int J Cancer. 2008;122(12):2656-64.
D'Souza G, Kreimer AR, Viscidi R, Pawlita M, Fakhry C, Koch WM, Westra WH, Gillison ML. Case-control study of human papillomavirus and oropharyngeal cancer. N Engl J Med. 2007;356(19):1944-56.
D'Souza G, Agrawal Y, Halpern J, Bodison S, Gillison ML. Oral sexual behaviors associated with prevalent oral human papillomavirus infection. J Infect Dis. 2009;199(9):1263-9.
Dunne EF, Nielson CM, Stone KM, Markowitz LE, Giuliano AR. Prevalence of HPV infection among men: A systematic review of the literature. J Infect Dis. 2006;194(8):1044-57.
Kreimer AR, Clifford GM, Boyle P, Franceschi S. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol Biomarkers Prev. 2005;14(2):467-75.
Aguirre-Urizar JM, Lafuente-Ibáñez de Mendoza I, Warnakulasuriya S. Malignant transformation of oral leukoplakia: Systematic review and meta-analysis of the last 5 years. Oral Dis. 2021;27(8):1881-95.
Nunes Júnior SS, Ciosak SI. Terapia Antirretroviral Para Hiv/Aids: O Estado Da Arte, Rev enferm UFPE. 2018;12(4):1103-11.
Brasil. Ministério Da Saúde. Diretriz 2018 - Cuidado Contínuo À Saúde Do Portador. 2018. Disponível Em: Http://Www.Aids.Gov.Br. Acesso em: 04 Set. 2019.
Comparini RA, Silva ET, Pereira DCR. Estratégias De Ampliação Do Diagnóstico Da Infecção Pelo Vírus Da Imunodeficiência Humana No Brasil. Com Ciências Saúde. 2017;28(2):158-67.
Graham SV, Faizo AAA. Control of human papillomavirus gene expression by alternative splicing. Virus Res. 2017;231:83-95.
Estêvão D, Costa NR, Gil da Costa RM, Medeiros R. Hallmarks of HPV carcinogenesis: The role of E6, E7 and E5 oncoproteins in cellular malignancy. Biochim Biophys Acta Gene Regul Mech. 2019;1862(2):153-62.
de Martel C, Plummer M, Vignat J, Franceschi S. Worldwide burden of cancer attributable to HPV by site, country and HPV type. Int J Cancer. 2017;141(4):664-70.
Ndiaye C, Mena M, Alemany L, Arbyn M, Castellsagué X, Laporte L, Bosch FX, de Sanjosé S, Trottier H. HPV DNA, E6/E7 mRNA, and p16INK4a detection in head and neck cancers: a systematic review and meta-analysis. Lancet Oncol. 2014;15(12):1319-31.
Graham SV. The human papillomavirus replication cycle, and its links to cancer progression: a comprehensive review. Clin Sci (Lond). 2017;131(17):2201-21.
Giuliano AR, Lee JH, Fulp W, Villa LL, Lazcano E, Papenfuss MR, Abrahamsen M, Salmeron J, Anic GM, Rollison DE, Smith D. Incidence and clearance of genital human papillomavirus infection in men (HIM): a cohort study. Lancet. 2011;377(9769):932-40.
Rowhani-Rahbar A, Hawes SE, Sow PS, Toure P, Feng Q, Dem A, Dembele B, Critchlow CW, N'Doye I, Kiviat NB. The impact of HIV status and type on the clearance of human papillomavirus infection among Senegalese women. J Infect Dis. 2007;196(6):887-94.
Grabowska AK, Riemer AB. The invisible enemy - how human papillomaviruses avoid recognition and clearance by the host immune system. Open Virol J. 2012;6:249-56.
Tugizov S. Virus-associated disruption of mucosal epithelial tight junctions and its role in viral transmission and spread. Tissue Barriers. 2021;9(4):1943274.
Williams R, Lee DW, Elzey BD, Anderson ME, Hostager BS, Lee JH. Preclinical models of HPV+ and HPV- HNSCC in mice: an immune clearance of HPV+ HNSCC. Head Neck. 2009;31(7):911-18.
House R, Majumder M, Janakiraman H, Ogretmen B, Kato M, Erkul E, Hill E, Atkinson C, Barth J, Day TA, Palanisamy V. Smoking-induced control of miR-133a-3p alters the expression of EGFR and HuR in HPV-infected oropharyngeal cancer. PLoS One. 2018;13(10):e0205077.
Kumar B, Cordell KG, Lee JS, Prince ME, Tran HH, Wolf GT, Urba SG, Worden FP, Chepeha DB, Teknos TN, Eisbruch A, Tsien CI, Taylor JM, D'Silva NJ, Yang K, Kurnit DM, Bradford CR, Carey TE. Response to therapy and outcomes in oropharyngeal cancer are associated with biomarkers including human papillomavirus, epidermal growth factor receptor, gender, and smoking. Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S109-11.
Zhai L, Tumban E. Gardasil-9: A global survey of projected efficacy. Antiviral Res. 2016;130:101-9.
Irimie AI, Braicu C, Cojocneanu R, Magdo L, Onaciu A, Ciocan C, et al . Differential Effect of Smoking on Gene Expression in Head and Neck Cancer Patients. Int J Environ Res Public Health. 2018;15(7):1558.
Sobral APV, Almeida HCR, Fontes JPS. Correlação Do Papilomavírus Humano Com O Carcinoma Epidermóide Bucal: Revisão Sistemática. Rev cir traumatol buco-maxilo-fac. 2014;14(2):95-102.
Gillison ML, Koch WM, Capone RB, Spafford M, Westra WH, Wu L, et al. Evidence for a causal association between human papillomavirus and a subset of head and neck cancers. J Natl Cancer Inst. 2000;92(9):709-20.
Reis D. Kormann LA, Manfron APT. Bettega PVC, Moraes SH, Moraes GF. Lesões Orais do vírus HPV: revisão de literatura. RGS.2020;22(2):19-28.
